• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ON-X ASCENDING AORTIC PROSTHESIS WITH THE VASCUTEK GELWEAVE VALSALVA GRAFT; HEART VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ON-X ASCENDING AORTIC PROSTHESIS WITH THE VASCUTEK GELWEAVE VALSALVA GRAFT; HEART VALVE, MECHANICAL Back to Search Results
Model Number ONXAAP-25
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Thrombosis/Thrombus (4440)
Event Date 05/06/2018
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.
 
Event Description
According to initial notification "patient is in the post-market clinical follow-up study protocol of the on-x ascending aortic prosthesis (aap) retrospective study and was implanted on (b)(6) 2018 with a prefabricated aap device sn (b)(6).On (b)(6) 2018 (1 day post implant) was noted with minimal response after surgery.The subject¿s relevant history is as follows.The subject has been previously admitted in (b)(6) 2018 due to ischemic stroke in the right cerebellum due to embolism from thrombosis of a mechanical aortic valve.He was discharged to rehab and then readmitted on (b)(6) 2018.An mri performed on (b)(6) 2018 showed multiple new foci of diffusion restriction intracranially in both hemispheres compatible with new interval embolic phenomenon compared to (b)(6) 2018 study.A tee was performed (date unknown) showing annular thrombosis and unroofing with a mobile mass with a thin stalk in the lvot coming from the annulus.The re-do aortic valve repair with ascending aortic replacement was done on (b)(6) 2018.On (b)(6) 2018 a repeat mri was performed showing small probable acute ischemic focus involving posterior right occipital lobe that was not visualized on prior ct or mr study.A repeat ct was performed on (b)(6) 2018 showing no new abnormalities.The subject was discharged on (b)(6) 2018 back to rehab." this investigation is relegated to onxaap-25, sn (b)(6).
 
Manufacturer Narrative
Per the adjudication received, this event is not valve related.Per medical device reporting for manufacturers- fda guidance for industry and food and drug administration staff, section 2.16 an mdr report is not required when "you have information that would enable a person who is qualified to make a medical judgement to reasonable conclude that your device did not cause or contribute to a death or serious injury, or that a malfunction would not be likely to cause or contribute to a death or serious injury, if it were to recur." therefore, further investigation is not warranted.Per adjudication received, this event is not valve related; therefore, further investigation is not necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-X ASCENDING AORTIC PROSTHESIS WITH THE VASCUTEK GELWEAVE VALSALVA GRAFT
Type of Device
HEART VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 east anderson lane
building b
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES, INC.
1300 east anderson lane
building b
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts boulevard nw
kennesaw, GA 30144
7704193355
MDR Report Key18594851
MDR Text Key333959912
Report Number1649833-2024-00015
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier00851788001532
UDI-Public00851788001532
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberONXAAP-25
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/22/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/01/2016
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization; Life Threatening;
-
-